2023
DOI: 10.1111/dar.13630
|View full text |Cite
|
Sign up to set email alerts
|

How do patients and staff in an opioid agonist treatment service view smoking cessation medications and e‐cigarettes?

Abstract: Introduction Tobacco use and related mortality is common in people receiving opioid agonist treatment (OAT). Smoking cessation medications are available and e‐cigarettes are increasingly recommended for high risk populations. This study explores experience, knowledge and attitudes around smoking cessation medications (nicotine replacement therapy [NRT], bupropion and varenicline) and e‐cigarettes in patients and clinicians in two public Australian OAT clinics. Methods Cross‐sectional surveys of patients and cl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 33 publications
0
0
0
Order By: Relevance